Clinical outcomes following switch from risankizumab to guselkumab in Crohn’s disease: a real-world case series
- DOI
- 10.1093/ecco-jcc/jjag089
- Published
- 2026-06
- Container
- Journal of Crohn's and Colitis
- Publisher
- Oxford University Press (OUP)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1093/ecco-jcc/jjag089,
title = {Clinical outcomes following switch from risankizumab to guselkumab in Crohn’s disease: a real-world case series},
author = {Amar Farkouh and Nabil Nathoo-Khedri and Alice Dufresne and Homa Danaie and Robert Battat},
year = {2026},
journal = {Journal of Crohn's and Colitis},
doi = {10.1093/ecco-jcc/jjag089},
url = {https://doi.org/10.1093/ecco-jcc/jjag089}
}RIS
TY - JOUR TI - Clinical outcomes following switch from risankizumab to guselkumab in Crohn’s disease: a real-world case series AU - Amar Farkouh AU - Nabil Nathoo-Khedri AU - Alice Dufresne AU - Homa Danaie AU - Robert Battat PY - 2026 JO - Journal of Crohn's and Colitis DO - 10.1093/ecco-jcc/jjag089 UR - https://doi.org/10.1093/ecco-jcc/jjag089 ER -
APA
Farkouh, A., Nathoo-Khedri, N., Dufresne, A., Danaie, H., & Battat, R. (2026). Clinical outcomes following switch from risankizumab to guselkumab in Crohn’s disease: a real-world case series. Journal of Crohn's and Colitis. https://doi.org/10.1093/ecco-jcc/jjag089
Source records
- crossref · retrieved 2026-09-26T20:51:37.528Z